Quick Answer
Imunon, Inc. reported Stockholders Equity of $7.06 million for fiscal year 2025.
Imunon, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.06M | +66.4% |
| 2024 | $4.24M | -68.3% |
| 2023 | $13.39M | -54.4% |
| 2022 | $29.33M | -47.4% |
| 2021 | $55.80M | +199.8% |
| 2020 | $18.61M | +27.8% |
| 2019 | $14.56M | -30.2% |
| 2018 | $20.86M | -21.9% |
| 2017 | $26.70M | +297.0% |
| 2016 | $6.73M | -67.0% |
| 2015 | $20.39M | -37.9% |
| 2014 | $32.83M | +4.1% |
| 2013 | $31.52M | +163.5% |
| 2012 | $11.96M | -54.3% |
| 2011 | $26.19M | +672.5% |
| 2010 | -$4.58M | -145.6% |
| 2009 | $10.04M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.08M | -50.2% | +53.5% |
| June 30, 2025 | $2.66M | -28.9% | +488.4% |
| March 31, 2025 | $452.0K | -94.7% | -89.3% |
| December 31, 2024 | $4.24M | -68.3% | -48.2% |
| September 30, 2024 | $8.19M | -54.7% | +119.0% |
| June 30, 2024 | $3.74M | -82.6% | -56.0% |
| March 31, 2024 | $8.50M | -68.1% | -36.5% |
| December 31, 2023 | $13.39M | -54.4% | -25.9% |
- Imunon, Inc. showed an increase of +66.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, Imunon, Inc.’s stockholders equity has declined by 29.6% (from $10.04 million to $7.06 million).
- The most recent figure is from Imunon, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: